Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Chao Lin

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Scientific Reports|October 9, 2025
An AIoT enabled system for optimizing data retrieval in the intensive care unit evaluated in a randomized crossover pilot trialHow-Yang Tseng, Wen-Sheng Feng, Chieh-Lung Chen, et al.
Critical Care (London, England)|August 22, 2022
Using real-time visualization system for data-driven decision support to achieve lung protective strategy: a retrospective observational studyHow-Yang Tseng, Chieh-Lung Chen, Yu-Chao Lin, et al.
Frontiers in Oncology|July 26, 2021
The Effectiveness and Safety of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer Patients With Stage III/IV: A Multicenter StudyJason C Hsu, Phung-Anh Nguyen, Yen-Tzu Chen, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Scientific Reports|October 9, 2025
An AIoT enabled system for optimizing data retrieval in the intensive care unit evaluated in a randomized crossover pilot trialHow-Yang Tseng, Wen-Sheng Feng, Chieh-Lung Chen, et al.
Critical Care (London, England)|August 22, 2022
Using real-time visualization system for data-driven decision support to achieve lung protective strategy: a retrospective observational studyHow-Yang Tseng, Chieh-Lung Chen, Yu-Chao Lin, et al.
Frontiers in Oncology|July 26, 2021
The Effectiveness and Safety of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer Patients With Stage III/IV: A Multicenter StudyJason C Hsu, Phung-Anh Nguyen, Yen-Tzu Chen, et al.
Pageof 6